Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: AstraZeneca UK Ltd., 600 Capability Green, Luton, LU1 3LU, UK
Bambec Tablets 10 mg.
| Pharmaceutical Form |
|---|
|
Tablet. |
Each tablet contains 10 mg Bambuterol hydrochloride.
Excipient(s) with known effect: Each tablet contains 63 mg of lactose (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Bambuterol is an active precursor of the selective β2-adrenergic agonist terbutaline. Bambuterol is the bis-N,N-dimethyl-carbamate of terbutaline. Bambuterol is a remarkably selective and potent inhibitor of cholinesterase. Bambuterol is indicated for the management of asthma, bronchospasm and/or reversible airways obstruction. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Amber glass bottle with LD-polyethene cap: 7, 14, 28, 30, 56 or 100 tablets.
HDPE container with LD-polyethene cap: 7, 14, 28, 30, 56 or 100 tablets.
HDPE container with polypropylene cap: 7, 14, 28, 30, 56 or 100 tablets.
PVC blisters: 7, 14, 28, 30, 56 or 100 tablets.
Not all pack sizes may be marketed.
AstraZeneca UK Ltd., 600 Capability Green, Luton, LU1 3LU, UK
PL 17901/0103
Date of first authorisation: 4th August 1992
Date of latest renewal: 21st May 2002
| Drug | Countries | |
|---|---|---|
| BAMBEC | Austria, Brazil, Germany, Spain, Singapore, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.